McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.

Revenue
+7.57%
EPS
+17.0%
Free cash flow
+32.5%
Total debt
+7.08%

Quarter to September 2026, against a year earlier

1,061.69 10.31 −0.96%
Market cap
$125.0B
P/E
27.5×
Fwd P/E
25.4×
Dividend yield
0.32%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26 From the 10-Q filed 4 Nov
Piotroski F-Score

+8 more TTM periods

7 7 7 7
ROE
(240.78%) (274.39%) (168.45%) (190.51%)
ROA
5.59% 6.05% 5.41% 5.33%
ROIC
45.30% 66.20% 70.49% 114.15%
Return on Tangible Assets
(74.83%) (66.70%) (94.97%) (93.14%)
Average Days of Receivables
25.88 25.32 26.92 26.85
Free Cash Flow per Share
78.28 43.77 51.77 59.05
Free Cash Flow
9,644.00 5,410.00 6,145.00 6,868.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 4 Nov 2026